Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20546441rdf:typepubmed:Citationlld:pubmed
pubmed-article:20546441lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:20546441lifeskim:mentionsumls-concept:C0009324lld:lifeskim
pubmed-article:20546441lifeskim:mentionsumls-concept:C0085149lld:lifeskim
pubmed-article:20546441lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:20546441lifeskim:mentionsumls-concept:C0666743lld:lifeskim
pubmed-article:20546441lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:20546441pubmed:issue5lld:pubmed
pubmed-article:20546441pubmed:dateCreated2010-6-15lld:pubmed
pubmed-article:20546441pubmed:abstractTextLittle is known about the efficacy and safety of infliximab for ulcerative colitis refractory to tacrolimus. The aim of this study was to evaluate the efficacy and safety of infliximab in the induction of remission in ulcerative colitis patients with persistent symptoms despite tacrolimus therapy.lld:pubmed
pubmed-article:20546441pubmed:languageenglld:pubmed
pubmed-article:20546441pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20546441pubmed:citationSubsetIMlld:pubmed
pubmed-article:20546441pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20546441pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20546441pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20546441pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20546441pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20546441pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20546441pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20546441pubmed:statusMEDLINElld:pubmed
pubmed-article:20546441pubmed:monthMaylld:pubmed
pubmed-article:20546441pubmed:issn1440-1746lld:pubmed
pubmed-article:20546441pubmed:authorpubmed-author:YamamotoShuji...lld:pubmed
pubmed-article:20546441pubmed:authorpubmed-author:ChibaTsutomuTlld:pubmed
pubmed-article:20546441pubmed:authorpubmed-author:MasudaSatohir...lld:pubmed
pubmed-article:20546441pubmed:authorpubmed-author:NakaseHiroshi...lld:pubmed
pubmed-article:20546441pubmed:authorpubmed-author:InuiKen-ichiKlld:pubmed
pubmed-article:20546441pubmed:authorpubmed-author:MatsuuraMinor...lld:pubmed
pubmed-article:20546441pubmed:authorpubmed-author:HonzawaYusuke...lld:pubmed
pubmed-article:20546441pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20546441pubmed:volume25lld:pubmed
pubmed-article:20546441pubmed:ownerNLMlld:pubmed
pubmed-article:20546441pubmed:authorsCompleteYlld:pubmed
pubmed-article:20546441pubmed:pagination886-91lld:pubmed
pubmed-article:20546441pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:meshHeadingpubmed-meshheading:20546441...lld:pubmed
pubmed-article:20546441pubmed:year2010lld:pubmed
pubmed-article:20546441pubmed:articleTitleEfficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.lld:pubmed
pubmed-article:20546441pubmed:affiliationDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.lld:pubmed
pubmed-article:20546441pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20546441pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed